Literature DB >> 15916016

Sublingual specific immunotherapy reduces PBMC proliferations.

D Fenoglio1, F Puppo, I Cirillo, A Vizzaccaro, A Ferrera, M A Tosca, G Marseglia, G Ciprandi.   

Abstract

BACKGROUND: Subcutaneous specific immunotherapy has been demonstrated capable of inducing T regulatory response. There is few evidence concerning immunological changes induced by sublingual immunotherapy.
OBJECTIVE: The aim of this study was to evaluate T cell proliferation in subjects successfully treated with SLIT for HDM.
METHODS: PBMCs were isolated from patients after at least 3 years of successful HDM SLIT and from matched untreated allergic and healthy control subjects. After 3 and 6 days of in vitro stimulation with PHA, Candida albicans, Dermatophagoides farinae, grasses, Parietaria judaica, and cat, proliferation.
RESULTS: Subjects treated with SLIT showed significant reduction of proliferation induced by Candida albicans, Parietaria, and grasses in comparison with untreated atopics (p=0.0002, 0.0033, and 0.009 respectively).
CONCLUSION: This pilot study confirms reduced T cell proliferation in allergic subjects treated with SLIT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916016

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  4 in total

Review 1.  Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.

Authors:  Ivana Đurić-Filipović; Marco Caminati; Gordana Kostić; Đorđe Filipović; Zorica Živković
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

2.  Sub-lingual immunotherapy: world allergy organization position paper 2009.

Authors:  G Walter Canonica; Jean Bousquet; Thomas Casale; Richard F Lockey; Carlos E Baena-Cagnani; Ruby Pawankar; Paul C Potter; Philippe J Bousquet; Linda S Cox; Stephen R Durham; Harold S Nelson; Giovanni Passalacqua; Dermot P Ryan; Jan L Brozek; Enrico Compalati; Ronald Dahl; Luis Delgado; Roy Gerth van Wijk; Richard G Gower; Dennis K Ledford; Nelson Rosario Filho; Erkka J Valovirta; Osman M Yusuf; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2009-11-19       Impact factor: 4.084

Review 3.  Mite immunotherapy.

Authors:  Enrique Fernández-Caldas; Victor Iraola; Manuel Boquete; Antonio Nieto; Miguel Casanovas
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

4.  Sublingual immunotherapy in allergic rhinitis.

Authors:  Doo Hee Han; Chae-Seo Rhee
Journal:  Asia Pac Allergy       Date:  2011-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.